WO2002072236A1 - Separation de particules - Google Patents
Separation de particules Download PDFInfo
- Publication number
- WO2002072236A1 WO2002072236A1 PCT/SE2002/000429 SE0200429W WO02072236A1 WO 2002072236 A1 WO2002072236 A1 WO 2002072236A1 SE 0200429 W SE0200429 W SE 0200429W WO 02072236 A1 WO02072236 A1 WO 02072236A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particles
- particle type
- standing wave
- wave pattern
- ultrasonic standing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3479—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by dialysing the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3678—Separation of cells using wave pressure; Manipulation of individual corpuscles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/28—Mechanical auxiliary equipment for acceleration of sedimentation, e.g. by vibrators or the like
- B01D21/283—Settling tanks provided with vibrators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3375—Acoustical, e.g. ultrasonic, measuring means
Definitions
- the present invention deals with separation of particles in a fluid comprising particulate matter. Especially the present invention relates to a method and an apparatus for separating particles, and more specifically for separating particles in a blood solution by means of an acoustic filter using ultrasound.
- particles or particulate matter comprised in a fluid subjected to an ultrasonic or acoustic standing wave field will be displaced to locations or positions at or in relation to the nodes or antinodes of the standing wave.
- certain patterns of accumulations of particles will be formed. This is an advantage when separating out particles or particulate matter of a certain weight and/or size from a medium containing a spectrum of particles or particulate matter of different density or acoustic impedance.
- particles having a density higher than the fluid without particles accumulate in or in the proximity of the nodes, and particles having a density lower than the fluid without particles, accumulate in or in the proximity of the antinodes.
- particle separation is important when recycling blood in connection with major surgical operations, were the separation is carried out by means of so called blood washing.
- This method of recycling blood is particularly advantageous in surgical operations when the patient looses large amounts of blood and the need of expensive blood transfusions decreases. Furthermore, the risk for infection and immunization is decreased since the patient's own blood is recycled.
- blood washing is performed only in extreme cases, since the methods today suffers from low availability and a demand for comparatively expensive manual handling. Instead blood is often recycled unwashed, but more often expensive blood transfusions are used.
- blood that is lost in connection with a heart operation comprises blood plasma with a number of harmful substances, such as fat emboli. If this lost blood is recycled to the patient without preceding blood washing, these fat emboli can cause thrombus formation, i.e. clots of fat, in the brain.
- fat emboli can cause thrombus formation, i.e. clots of fat, in the brain.
- activated complementary complex, deranged coagulation factors and massive fibrinolysis Increased levels of a number of protein usually used as serum markers for different types of organ damages have also been registered, entailing that these markers cannot be used with the previously expected specificity when diagnosing.
- Another important field for particle separation is the separation of blood plasma from blood cells, were the separated blood plasma can be used for example in dialysis treatment.
- Yet another important field for particle separation is the separation of blood plasma from blood cells in donated blood plasma. In the latter context there are generally no specific time aspects to deal with, as the case is when washing blood during surgical operation.
- the drifting standing wave characteristics is adjusted in such a way that the platelets passes through the standing wave to an exit port (320) and that the remaining particulate matter is carried with the drifting standing wave to the window (310). At the window (310), the remaining particulate matter is removed to the container (324) for diluted blood.
- this apparatus requires that all particulate matter that are not desired among the collected platelets are attached to the drifting standing wave and carried to the window (310). However, such a requirement is almost impossible to fulfill since different particle types have different acoustic properties and will thus, to a greater or less extent, attach to the drifting standing wave.
- US 4,743,361 does not disclose an apparatus comprising washing to remove undesired particles in the collected liquid comprising the desired particles.
- the US patent No. 5,484,537 shows another apparatus for manipulating particles in an ultrasonic field wherein a liquid is handled in an open system. Furthermore, the US patent No. 4,055,491 shows an apparatus and a method for separation of particles by means of ultrasound based on flocculation and sedimentation of particles to be separated.
- the US patent No. 5,831,166 shows the manipulation of micro-particles by means of ultrasound, wherein a concave ultrasound transmitter is positioned in a solution containing micro-particles. Further a reflector is arranged in the focus of the concave ultrasound transmitter, and during operation standing waves are generated between the ultrasound transmitter and the reflector. Due to the fact that an ultrasound field is generated by a concave ultrasound transmitter, the amplitude of the standing wave will have its maximum in the vicinity of the reflector and thereby comparatively stable sonar field points are concentrated to the vicinity of the reflector. It is possible for the micro-particles to be collected in these more stable points and hence the particles are not affected to any particular extent by variations in the ultrasound frequency.
- the general object of the present invention is to solve the problem of providing an increased separation of particles in blood, i.e. to separate with a higher degree of purification blood cells from blood plasma and possible pollutants.
- the invention also aims to solve the following aspects of the problem: to provide separation of particles in a system not suffering of a blocked separation filter or decreased permeability with time due to particles clogging in the separation filter, to provide an increased process speed, to provide particle separation in a process, which to a high degree is automatic and requires a minimum of users and a minimum of a user's time for managing the equipment, to provide a system for separation of particles in blood such that the risk for contamination in the processed blood liquid is decreased, to provide a blood washing system enabling an automatic blood washing process, and to provide a system which is more gentle to the cells, as compared to existing techniques utilizing centrifugal force.
- the stated problem is solved in accordance with the invention by generating in blood a ultrasonic standing wave pattern such that particles having a certain property is displaced by forces from the standing wave into a position in one of the nodes of the standing wave. In this manner there is collecting and holding in the nodes of such particles that for example has a certain size in relation to the wavelength of the generated ultrasonic wave pattern.
- the blood or a rinsing fluid flows through the standing wave pattern one type of particles is held in the nodes while another type of particles is flowing through and past the standing wave pattern, which then achieves the function of a filter.
- an acoustic filter is achieved, more specifically an ultrasonic filter that can be used to concentrate one of the particle types in the ultrasonic standing wave pattern and to collect the other particle types in another position.
- the selection of particles to be caught by the acoustic filter can be based on controlling other parameters than sound wavelength, frequency, for example the distance between the ultrasound transmitter and reflector. Further, the selection of particles held in the nodes can be controlled dependent on their acoustical properties, e.g. their acoustic impedance, which depends on the density of the blood solution. Thus, dependent on the density, compressibility and size of the particles certain patterns of accumulations of particles will be formed in the blood solution exposed the ultrasonic field.
- the acoustic filter is realized in what could be called a macro-dimension, with an ultrasound generator applied in or on a liquid container accommodating a magnitude of 10-100 ml liquid.
- a larger liquid container can be used, in some embodiments of the invention the liquid container accommodates a magnitude of 10-500 ml.
- Separated blood refers to the resulting solution or liquid after particle separation.
- This liquid contains blood cells, preferably an increased concentration of blood cells, together with blood plasma or rinsing solution and possible contamination substances.
- the rinsing solution is for example a sodium solution, such as a sodium chloride solution, a Ringer's solution or a glucose solution.
- the contamination can include air bubbles, fat particles, coagulation products or other not desirable biological material.
- the amount of blood plasma and possible contamination substances is related to the time during which the particle separation according to the present invention has been performed.
- the liquid includes only blood cells and a possible carrier fluid, e.g. a rinsing fluid.
- Collected blood is blood that has been collected from a living being, and comprising blood plasma and possible contamination substances such as fat emboli, complementary complexes, deranged coagulation factors, cytostatics and/or massive fibrinolysis.
- Acoustic filter refers to the functional filter that occurs when standing waves are generated between an ultrasound transmitter and a reflector.
- the filter When the filter is applied in a liquid, particles or substances comprised in or suspended in the liquid are subjected to forces exerting the particles towards the nodes or antinodes of the standing waves. The particles will thereby be arranged at different locations depending on their physical and acoustic properties. Particles having a certain size, density and/or compressibility are for example held or fixed in the nodes of the standing waves and particles having another size, density and/or compressibility can be carried with a rinsing fluid through the field of the standing waves.
- the applied ultrasound has the function of a filter in which particles having a certain size are concentrated and fixed.
- the size of the particles that are caught in the filter can be varied dependent on the distance between the ultrasound transmitter and the reflector or dependent on the ultrasound frequency. Furthermore, different particles having the same size can be separated dependent on their acoustic properties or density.
- Nodes refer to pressure nodes of a generated ultrasonic standing wave, where particles of higher density than the solution or medium and/or lower compressibility will tend to accumulate, due to the inherent physical properties of the ultrasound standing wave.
- Antinodes refer to pressure nodes of a generated ultrasonic standing wave, where particles of lower density than the solution or medium and/or higher compressibility will tend to accumulate, due to the inherent physical properties of the ultrasound standing wave.
- Particles refers to cells, such as red and white blood cells, virus, proteins, molecules, or to accumulations of substances or matters
- Micro-particles refer to particles having a diameter less than 15 ⁇ m.
- Fig la and lb shows schematically flows of liquid to and from a separation container in accordance with the invention
- Fig 2 shows a first exemplifying embodiment of the system in accordance with the present invention
- Fig 3 shows a second exemplifying embodiment of the system in accordance with the present invention.
- Fig 4 shows schematically an embodiment using gravity for the mechanism for generating a liquid flow.
- the present invention is directed to the separation of particles or particulate matter suspended in a solution and particularly to the separation of particles, mostly micro-particles comprised in a solution. Further, the invention refers to separation and subsequent washing of particles.
- the present invention is capable to separate particles of a first particle type from particles of a second particle type suspended in a solution, for example to separate cells in a suspension. More specifically the present invention can be used to separate for example bacteria, virus, protozoa, red and white blood cells, stem cells or another kind of cells from a living being. Further, the inventive concept can be used in other microbiological techniques for separating microorganism from a cell culture.
- the present invention will be described by means of separation of micro-particles from a blood solution or blood collected from a living being.
- the present invention can be used for separating other particles or particulate matters comprised or suspended in a solution.
- Fig. la and lb show schematically flows of collected blood, rinsing fluid, blood plasma containing possible contaminating substances and separated blood to and from a separation container, which separation container is comprised in an apparatus in accordance with the present invention.
- micro-particles such as blood cells can be separated from blood plasma, by means of a closed system in accordance with the invention where separated particles as well as remaining liquid or solution are collected in two separate containers. Since collected blood comprises contaminating substances these are separated together with the blood plasma from the blood cells, whereby the washing or purification of the blood is achieved whereupon the separated blood can be infused in a patient. In cases where collected blood from a living being is free from or only contains a small amount of contaminated substances, a separation of only blood plasma from blood cells can be performed and the separated blood plasma can be infused in a patient.
- An embodiment of the present invention thus comprises a closed system for particle separation, by means of which particles in for example collected blood can be separated.
- One embodiment of the particle separation comprises the steps of:
- a sterile priming solution preferably a sodium chloride solution or a glucose solution
- the apparatus thus comprises two fluid circuits. Firstly, a first circuit where collected blood is supplied to the separation container, whereby superfluous priming solution is forced to flow out of the separation container. Secondly, a second circuit where the rinsing fluid is supplied to the separation container and collected blood is flowing through the separation container and the acoustic filter, whereupon particles in the blood are caught in the filter and whereupon blood plasma and possible contaminating substances flow unaffected through the filter out in the separation container.
- FIG. 2 shows a more detailed embodiment of an apparatus for performing the steps described above.
- a sterile separation container 500 which has been treated with an anticoagulation agent, is filled with a sterile priming solution preferably in the form of a sodium chloride solution or a glucose solution, in order to avoid for example air or air bubbles in the system.
- a sterile priming solution preferably in the form of a sodium chloride solution or a glucose solution, in order to avoid for example air or air bubbles in the system.
- blood to be separated is collected, for example blood lost during a surgical operation.
- the collected blood is put in a first sterile container 100, which preferably also have been treated with an anticoagulation agent.
- Collected blood is thereafter arranged to flow by means of a flowing mechanism in the shape of a first activating device 120, for example a roller pump, into the separation container 500 through a first inlet 501 of the separation container 500 and a first sealed connection 110 to a predetermined level, preferably at level with the ultrasound transmitter 510 and the reflector 520.
- a first activating device 120 for example a roller pump
- only the first connection 110 and the first inlet 501, and the second sealed connection 210 and a second outlet 502 of the separation container 500 are open, when supplying collected blood to the separation container 500.
- a part of the priming solution present in the separation container 500 is forced to flow out of the second outlet 502 of the separation container 500 through the second connection 210 to a second sterile container 200.
- the supplying of collected blood to the separation container 500 is stopped manually, but it is also conceivable to provide one or several sensors arranged on the separation container 500 in order to control the supply.
- the sensors can for example be arranged to register the amount of collected blood in the container 500 or the amount of collected blood supplied to the container 500 via the first connection 110.
- the first connection 110 is closed by means of the first activating means 120.
- An ultrasonic standing wave pattern 505 having a suitable frequency in the range of 0.5-10 MHz, preferably in the range of 2 MHz, is applied or generated by means of the ultrasound transmitter 510 over a predetermined part, area or space of the upper part of the separation container 500.
- the generated ultrasonic standing wave pattern 505 is preferably a static or stationary standing wave pattern, i.e. the frequency of the ultrasonic field is static or constant.
- the separation container 500 is preferably dimensioned such that an ultrasonic standing wave pattern 505 is occurring between the ultrasound transmitter 510 and the reflector 520, whereupon said part of the separation container 500 forms an acoustic filter.
- a sterile rinsing fluid preferably a sodium chloride solution or a glucose solution, is arranged to flow from a third sterile container 300 by means of a third actuating mechanism 320, for example a roller pump, into a second inlet 503 of the separation container 500 through a third sealed connection 310.
- the third connection 310 is in one embodiment of the invention arranged in the same part of the separation container 500 as the first connection 110.
- the flow of rinsing fluid causes collected blood to flow upwards in the separation container 500 through the acoustic filter, whereby the generated ultrasonic standing wave pattern causes the blood cells to be concentrated and fixed in the acoustic filter, e.g. in the nodes of the generated standing ultrasonic wave pattern.
- the second outlet 502 and the second connection 210 are open in addition to the open second inlet 503 and the open third connection 310, whereupon the rinsing fluid that flows through the separation container 500 causes collected blood plasma and possible contaminating substances to pass substantially unaffected by the ultrasonic standing wave pattern out of the separation container 500 through the second connection 210 to the second container 200.
- aggregations or accumulations of blood cells are achieved in the nodes of the ultrasonic standing wave pattern, which accumulations of blood cells or particle clusters tend to move downwards due to the larger gravitational force.
- the flow of rinsing fluid is stopped by means of the third activating mechanism 320, whereupon the separated blood by means of the fourth activating means 420, preferably a roller pump, is pumped out of a first outlet 504 of the separation container 500 through a fourth sealed connection 410 to a sterile container 400 for separated blood.
- the fourth activating means 420 preferably a roller pump
- the suitable level of flow rate depends on the fluid that is to be washed and its degree of contamination, but can in many cases be in the range of 100-1000 ml per hour and preferably in the range of 500 ml per hour.
- the first and a second connection 110 and 210, respectively, are preferably arranged in a sealed connection with the lower and the upper part, respectively, of the separation container 500, or vice versa.
- the first connection 110 and the first inlet 501 are preferably arranged in the lower part of the separation container 500, and the second connection 210 and the second outlet 502 in the upper part of the separation container 500.
- the ultrasound transmitter 510 and the reflector 520 that are arranged on opposite sides of the separation container 500 are preferably designed with a plane and rectangular shape in order to generate an homogenous ultrasound field, which field generates transversal wave fronts in the separation container 500. Further, the generated homogenous ultrasonic standing wave pattern between the transmitter 510 and the reflector 520 will have a direction of propagation perpendicular to the flat surfaces of the transmitter 510 and the reflector 520.
- the ultrasound generating means 510 and the reflecting means 520 have the same or approximately the same diametrical dimensions in the following ranges: width 5-100 mm, height 5-100 mm and depth/thickness 1-5 mm.
- the thickness of the reflecting means depends on the material, which the reflecting means is constructed of, but the thickness should be one fourth of the wavelength or an even multiple of one fourth of the wavelength.
- the reflector 520 can further be implemented as a second passive ultrasound transmitter or a reflecting material, such as a metal or a ceramic material.
- the reflector may be integrated with the wall of the container 500 or even be a part of the container 500 wall.
- the ultrasound transmitter 510 is preferably realized in a piezoelectric material vibrating in thickness mode, whereby mechanical oscillations are provided.
- the frequency of the oscillations is provided in such a way that the wavelength is somewhat larger than the double diameter of the particles to be separated.
- the frequency is in the interval from 0.5-10 MHz, preferably in the range of 2 MHz.
- the frequency of 2 MHz has turned out to be advantageous in order to fix and concentrate micro-particles having a diameter in the range of 7 ⁇ m, such as red blood cells, in the acoustic filter. This frequency can however be varied dependent on the size of the particles to be fixed in the filter.
- the applied frequency is preferably such that the diameter of the particles to be separated, that is the particles to be fixed, are less than half the wavelength of the waves.
- the ultrasound transmitter 510 is connected to a control unit 550 applying a voltage over the ultrasound transmitter 510.
- This voltage is in the range of 10 - 100 Vpp, and preferably in the range of 15- 50 Vpp.
- the suitable order of magnitude of the applied voltage depends on the material of the ultrasound generating means, since a too large applied voltage can cause the ultrasound generating means 510 to get out of order.
- a voltage of about 30 Vpp is applied when the frequency is about 2MHz and a voltage less than approximately 25 Vpp is applied when the frequency is about 4 MHz.
- control unit 550 is arranged to control the ultrasound energy delivered by the ultrasound generating means 510 and arranged to deliver electrical energy of a certain waveform, frequency and power.
- the waveform is controllable to be one of, but not limited to, sinus form, triangular form or square form.
- the reflecting means or reflector 520 can be realized as passive ultrasonic generating means or as means consisting of an ultrasonic reflecting material, such as a metal or a ceramic material. Further, the reflectors 520 can be integrated with the wall of the container 500 or even be a part of the container 500 wall. In the latter case, the chamber 500 wall is preferably manufactured of a material having desired reflecting properties to reflect the generated ultrasonic wave substantially unmodified.
- the ultrasound generating means 510 and the reflecting means 520 can be arranged in acoustic connection with the separation container 500.
- the generating means 510 and the reflecting means 520 are separated a distance in the range of 5-100 mm, preferably a distance of about 30 mm.
- the transmitters 510 and the reflectors 520 can also be arranged on the inside or outside of the separation container 500. If the transmitters 510 and the reflectors 520 are arranged on the inside of the container 500, they should be manufactured of a material that does not interact with or affect the solution in the separation container 500. If on the other hand the transmitters 510 and the reflectors 520 are arranged on the outside of the separation container 500, the walls of the separation container 500 should be manufactured of a material not affecting the generated ultrasonic standing wave pattern, i.e. of a material transparent or permeable for the generated ultrasonic field.
- a second exemplifying embodiment is shown in fig 3, however being based on the same principle for particle separation as described above.
- the flow from the container 100 containing collected blood is directed to the separation container 500 by means of a first 110a branch of the first connection 110 and the flow from the separation container 500 to the container 400 for separated blood is directed by means of a second 110b branch of the first connection 110.
- the flow via the first 110a and second 110b branch is controlled by means of the activating means 120 and by the control devices 130a and 130b, which preferably are realized by means of electromagnetic valves.
- a first online sensor 140 positioned close to the first connection 110.
- This first on-line sensor 140 detects for example the concentration of red blood cells, that is haematocrit.
- the second on-line sensor 240 e.g. a spectrophotometer, can be arranged in connection to the other connection 210 for detecting for example the concentration of contamina- ting substances being flushed out of the separation container 500. This second sensor 240 can thus control the time during which the separation takes place.
- the other sensor 240 can also be arranged such that it detects haematocrit and possible the occurrence of air in the flushed fluid.
- all components such as container 100, 200, 300, 400, 500, connections 110, 210, 310, 410 and branches 110a, 110b, comprised in the apparatus according to embodiments of the invention are preferably sterile and treated with an anti-coagulation agent, such as heparin, citrate or ACD (acid citrate dextrose).
- an anti-coagulation agent such as heparin, citrate or ACD (acid citrate dextrose).
- the present invention further comprises different embodiments of apparatuses, by means of which the above described particle separation can be carried out.
- Embodiments of the apparatuses would comprise actuating mechanisms 120, 220, 320 and in one embodiment also actuating means 420 and control devices 130a, 130b, ultrasound transmitter 510 and reflector 520 and sensors 140, 240.
- the separation container 500 can be connected to the apparatus, and the ultrasound transmitter 510 and the reflector 520 can be arranged in sealed connection against the separation container 500, the latter being separated at a mutual distance preferably in the range of 5-30 mm.
- the containers 100, 200, 300, 400 are therefore arranged in sealed connection with the separation container 500 by means of said connections 110, 210, 310 and in a second embodiment by means of connection 410.
- the sensors 140, 240 can be arranged at the apparatus such that they are positioned outside the connections 110, 210.
- the apparatus may further comprise a not shown user interface, preferably a display and keyboard, by means of which the apparatus can present data to a user and/or the user can input data to the apparatus, for example the processing time of the separation or the degree of purity of the blood desired by the user.
- Fig 4 shows schematically a very simple embodiment of the invention in which the flow of fluid is based on gravitation.
- a container 401 which may be a rigid cup, bag or the like, is provided with an ultrasound generator 407 on the outside, the inside or integrated with the container wall.
- the container 401 is provided with an outlet 403 and possible also an inlet 402, which possibly are provided with a closeable valve.
- the container 401 is filled with a liquid in the shape of blood 405 and the ultrasound generator 407 generates a standing wave 409, in the nodes of which particles of a certain particle type having certain physical properties are collected. Due to gravitation fluid is flowing out of the container 401 while said particles are held in the standing wave. In this way the concentration of said particles can be increased in the fluid 405 and be flushed out or removed after disactivating the standing wave.
- the container 401 can at the inlet 402 or the outlet 403 of course be connected to selectable containers for inputting blood or rinsing fluid, respectively, or for gathering rinsing fluid or particle concentration. It is considered that such simple embodiments of the invention can be used for alternative service conditions or as a low cost product.
- the separation container 500 is in one embodiment realized in a suitable disposable material that is transparent to the applied or generated ultrasound field, that is a material which does not or to a low extent affect the applied ultrasound field.
- the separation container 500 is preferably made out of plastic or a ceramic material.
- the walls of the separation container 500 should be sufficiently thick in order to provide a required degree of stability and on the other hand be sufficiently thin in order to reduce the interfering effect on the material on the applied ultrasound field.
- a suitable thickness of the walls should be in the range 0.2-3 mm, and in a preferred embodiment the thickness is 1 mm.
- An embodiment of the separation container 500 has the diametrical dimensions in the following ranges: width 20-100 mm, height 20- 150 mm and depth 20-100 mm, and preferably 30 mm x 60 mm x 30 mm. Further, the separation container 500 is sterilized and treated with an anti-coagulation agent such as heparin, ACD (acid citrate dextrose) or citrate.
- an anti-coagulation agent such as heparin, ACD (acid citrate dextrose) or citrate.
- the ultrasound transmitter 510 and the reflector 520 are arranged to have corresponding shapes, and are preferably plane and rectangular in order to generate a homogenous ultrasound field.
- the ultrasound transmitter 510 is preferably constituted by a piezoelectric material, and presents a suitable frequency in the range of 0.5-10 MHz, wherein the wavelength is somewhat larger than the double diameter of the particles to be separated. Preferably the applied frequency is about 2 MHz.
- the ultrasound transmitter 510 is connected to a generator applying a voltage over the ultrasound transmitter 510. This voltage is in the range of 10 - 100 Vpp, preferably in the range of 15-50 Vpp.
- the reflector 520 can be constituted by a second passive ultrasound transmitter or by a reflecting material, such as a metal or a ceramic material.
- Embodiments of the ultrasound transmitter 510 and the reflector 520 are preferably designed with the same dimensions in the following ranges: width 10-100 mm, height 10-100 mm and depth 1-5 mm.
- the ultrasound transmitter 510 and the reflector 520 are further arranged on opposite sides of the separation container 500.
- Embodiments of the containers 100, 200, 300, 400 are preferably realized in a suitable sterile disposable material such as a plastic polymer or glass.
- the embodiments of the containers 100, 200, 300, 400 are on their insides treated with an anti-coagulation agent and they have the shape of a bag or a bottle with a volume in a range of 50-5000 ml, preferably in the range of 500 ml.
- connection 110, 210, 310, 410 are preferably realized as tubings made in a suitable disposable material such as polyurethane, PVC, silicone or other plastic.
- the connections are further arranged to have a suitable diameter to provide a desired throughput.
- the diameter of the tubings is preferably in the range of 1.5-2.5 mm.
- the connections are preferably also sterile and treated with an anticoagulation agent.
- An embodiment of the present invention realized as a kit of articles used for particle separation would comprise a separation container 500, a first and second container 100 and 200, respectively, and a third container 300 comprising a rinsing fluid and a fourth container 400 for separated blood.
- An embodiment of the kit would further comprise the first connection 110 having a first and a second branch 110a and 110b or a first connection 110 and a fourth connection 410.
- Embodiments of the kit would also comprise a second and a third connection 210 and 310, respectively. All the components of an embodiment of the kit would be sterile and treated with an anticoagulation agent. In one embodiment of the kit even the ultrasound transmitter 510 and the reflector 520 may be realized in suitable disposable materials.
- the invention also comprises a separation product for example a blood product resulting from a process in accordance with the steps of the inventive method.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Separation Of Solids By Using Liquids Or Pneumatic Power (AREA)
- External Artificial Organs (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100820-0 | 2001-03-09 | ||
SE0100820A SE0100820D0 (sv) | 2001-03-09 | 2001-03-09 | Particle separation using an acoustic filter |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002072236A1 true WO2002072236A1 (fr) | 2002-09-19 |
Family
ID=20283291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2002/000429 WO2002072236A1 (fr) | 2001-03-09 | 2002-03-11 | Separation de particules |
Country Status (2)
Country | Link |
---|---|
SE (1) | SE0100820D0 (fr) |
WO (1) | WO2002072236A1 (fr) |
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008037993A1 (fr) * | 2006-09-27 | 2008-04-03 | Prokyma Technologies Ltd | Procédé ultrasonore |
WO2009071733A1 (fr) | 2007-12-05 | 2009-06-11 | Consejo Superior De Investigaciones Cientificas | Microdispositif et procédé de séparation et d'extraction sélective et non invasive de particules en suspensions polydispersées, procédé de fabrication et applications correspondantes |
WO2009118551A1 (fr) * | 2008-03-25 | 2009-10-01 | Prokyma Technologies Limited | Procédé d'analyse de sang par ultrasons pour la caractérisation du sang, la détection d'anticorps et la cytométrie en écoulement |
WO2010082037A3 (fr) * | 2009-01-16 | 2010-10-21 | Isis Innovation Limited | Oscillateur acoustique |
US8134705B2 (en) | 2007-04-02 | 2012-03-13 | Life Technologies Corporation | Particle imaging systems and methods using acoustic radiation pressure |
US8614606B2 (en) | 2009-01-16 | 2013-12-24 | Salunda Limited | Delay-line self-oscillator |
US8685168B2 (en) | 2008-06-06 | 2014-04-01 | Industrial Technology Research Institute | Method for removing micro-debris and device of the same |
US8714014B2 (en) | 2008-01-16 | 2014-05-06 | Life Technologies Corporation | System and method for acoustic focusing hardware and implementations |
US8863958B2 (en) | 2007-04-09 | 2014-10-21 | Los Alamos National Security, Llc | Apparatus for separating particles utilizing engineered acoustic contrast capture particles |
US8932520B2 (en) | 2007-10-24 | 2015-01-13 | Los Alamos National Security, Llc | Method for non-contact particle manipulation and control of particle spacing along an axis |
US9038467B2 (en) | 2007-12-19 | 2015-05-26 | Los Alamos National Security, Llc | Particle analysis in an acoustic cytometer |
US9074979B2 (en) | 2004-07-29 | 2015-07-07 | Los Alamos National Security, Llc | Ultrasonic analyte concentration and application in flow cytometry |
US9494509B2 (en) | 2006-11-03 | 2016-11-15 | Los Alamos National Security, Llc | System and method for measuring particles in a sample stream of a flow cytometer using low-power laser source |
CN106178008A (zh) * | 2016-07-06 | 2016-12-07 | 中山大学 | 一种超声‑压电协同杀菌技术 |
WO2017063080A1 (fr) * | 2015-10-14 | 2017-04-20 | Sonosep Technologies Inc. | Procédés, systèmes et appareils permettant de séparer et de laver acoustiquement des particules |
US9733171B2 (en) | 2007-04-09 | 2017-08-15 | Los Alamos National Security, Llc | Acoustic concentration of particles in fluid flow |
WO2018034655A1 (fr) * | 2016-08-16 | 2018-02-22 | Flodesign Sonics, Inc. | Bioréacteur utilisant des ondes stationnaires acoustiques |
US10052431B2 (en) | 2014-06-09 | 2018-08-21 | Ascent Bio-Nano Technologies, Inc. | System for manipulation and sorting of particles |
US10308928B2 (en) | 2013-09-13 | 2019-06-04 | Flodesign Sonics, Inc. | System for generating high concentration factors for low cell density suspensions |
US10322949B2 (en) | 2012-03-15 | 2019-06-18 | Flodesign Sonics, Inc. | Transducer and reflector configurations for an acoustophoretic device |
US10662402B2 (en) | 2012-03-15 | 2020-05-26 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10689609B2 (en) | 2012-03-15 | 2020-06-23 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10724029B2 (en) | 2012-03-15 | 2020-07-28 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
US10737953B2 (en) | 2012-04-20 | 2020-08-11 | Flodesign Sonics, Inc. | Acoustophoretic method for use in bioreactors |
US10785574B2 (en) | 2017-12-14 | 2020-09-22 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
US10814253B2 (en) | 2014-07-02 | 2020-10-27 | Flodesign Sonics, Inc. | Large scale acoustic separation device |
WO2020227747A1 (fr) * | 2019-05-16 | 2020-11-19 | Felix Trampler | Dispositif de production d'un champ ultrasonore stationnaire |
US10947493B2 (en) | 2012-03-15 | 2021-03-16 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
US10975368B2 (en) | 2014-01-08 | 2021-04-13 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
US11007457B2 (en) | 2012-03-15 | 2021-05-18 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
US11420136B2 (en) | 2016-10-19 | 2022-08-23 | Flodesign Sonics, Inc. | Affinity cell extraction by acoustics |
US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4743361A (en) * | 1983-10-31 | 1988-05-10 | Internationale Octrooi Maatschappij "Octropa" Bv | Manipulation of particles |
US5484537A (en) * | 1990-03-14 | 1996-01-16 | Public Health Laboratory Service Board | Particle manipulation in an ultrasonic field |
US5831166A (en) * | 1996-01-23 | 1998-11-03 | Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry | Method of non-contact micromanipulation using ultrasound |
WO1998050133A1 (fr) * | 1997-05-03 | 1998-11-12 | University College Cardiff Consultants Ltd. | Manipulation de particules |
-
2001
- 2001-03-09 SE SE0100820A patent/SE0100820D0/xx unknown
-
2002
- 2002-03-11 WO PCT/SE2002/000429 patent/WO2002072236A1/fr not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4743361A (en) * | 1983-10-31 | 1988-05-10 | Internationale Octrooi Maatschappij "Octropa" Bv | Manipulation of particles |
US5484537A (en) * | 1990-03-14 | 1996-01-16 | Public Health Laboratory Service Board | Particle manipulation in an ultrasonic field |
US5831166A (en) * | 1996-01-23 | 1998-11-03 | Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry | Method of non-contact micromanipulation using ultrasound |
WO1998050133A1 (fr) * | 1997-05-03 | 1998-11-12 | University College Cardiff Consultants Ltd. | Manipulation de particules |
Cited By (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9074979B2 (en) | 2004-07-29 | 2015-07-07 | Los Alamos National Security, Llc | Ultrasonic analyte concentration and application in flow cytometry |
US10537831B2 (en) | 2004-07-29 | 2020-01-21 | Triad National Security, Llc | Ultrasonic analyte concentration and application in flow cytometry |
WO2008037993A1 (fr) * | 2006-09-27 | 2008-04-03 | Prokyma Technologies Ltd | Procédé ultrasonore |
US9494509B2 (en) | 2006-11-03 | 2016-11-15 | Los Alamos National Security, Llc | System and method for measuring particles in a sample stream of a flow cytometer using low-power laser source |
US8865476B2 (en) | 2007-04-02 | 2014-10-21 | Life Technologies Corporation | Particle switching systems and methods using acoustic radiation pressure |
US9457139B2 (en) | 2007-04-02 | 2016-10-04 | Life Technologies Corporation | Kits for systems and methods using acoustic radiation pressure |
US8309408B2 (en) | 2007-04-02 | 2012-11-13 | Life Technologies Corporation | Particle quantifying systems and methods using acoustic radiation pressure |
US10254212B2 (en) | 2007-04-02 | 2019-04-09 | Life Technologies Corporation | Particle analyzing systems and methods using acoustic radiation pressure |
US10969325B2 (en) | 2007-04-02 | 2021-04-06 | Life Technologies Corporation | Particle analyzing systems and methods using acoustic radiation pressure |
US9476855B2 (en) | 2007-04-02 | 2016-10-25 | Life Technologies Corporation | Particle analyzing systems and methods using acoustic radiation pressure |
US8846408B2 (en) | 2007-04-02 | 2014-09-30 | Life Technologies Corporation | Particle analyzing systems and methods using acoustic radiation pressure |
US8227257B2 (en) | 2007-04-02 | 2012-07-24 | Life Technologies Corporation | Medium switching systems and methods using acoustic radiation pressure |
US9134271B2 (en) | 2007-04-02 | 2015-09-15 | Life Technologies Corporation | Particle quantifying systems and methods using acoustic radiation pressure |
US8873051B2 (en) | 2007-04-02 | 2014-10-28 | Life Technologies Corporation | Methods and systems for controlling the flow of particles for detection |
US8900870B2 (en) | 2007-04-02 | 2014-12-02 | Life Technologies Corporation | Methods for fusing cells using acoustic radiation pressure |
US8134705B2 (en) | 2007-04-02 | 2012-03-13 | Life Technologies Corporation | Particle imaging systems and methods using acoustic radiation pressure |
US9733171B2 (en) | 2007-04-09 | 2017-08-15 | Los Alamos National Security, Llc | Acoustic concentration of particles in fluid flow |
US9339744B2 (en) | 2007-04-09 | 2016-05-17 | Los Alamos National Security, Llc | Apparatus for separating particles utilizing engineered acoustic contrast capture particles |
US8863958B2 (en) | 2007-04-09 | 2014-10-21 | Los Alamos National Security, Llc | Apparatus for separating particles utilizing engineered acoustic contrast capture particles |
US9909117B2 (en) | 2007-04-09 | 2018-03-06 | Los Alamos National Security, Llc | Systems and methods for separating particles utilizing engineered acoustic contrast capture particles |
US8932520B2 (en) | 2007-10-24 | 2015-01-13 | Los Alamos National Security, Llc | Method for non-contact particle manipulation and control of particle spacing along an axis |
WO2009071733A1 (fr) | 2007-12-05 | 2009-06-11 | Consejo Superior De Investigaciones Cientificas | Microdispositif et procédé de séparation et d'extraction sélective et non invasive de particules en suspensions polydispersées, procédé de fabrication et applications correspondantes |
US9038467B2 (en) | 2007-12-19 | 2015-05-26 | Los Alamos National Security, Llc | Particle analysis in an acoustic cytometer |
US11287362B2 (en) * | 2007-12-19 | 2022-03-29 | Triad National Security, Llc | Particle analysis in an acoustic cytometer |
US9488621B2 (en) | 2007-12-19 | 2016-11-08 | Los Alamos National Security, Llc | Particle analysis in an acoustic cytometer |
US11287363B2 (en) | 2007-12-19 | 2022-03-29 | Triad National Security, Llc | Particle analysis in an acoustic cytometer |
US20230168175A1 (en) * | 2008-01-16 | 2023-06-01 | Life Technologies Corporation | System And Method For Acoustic Focusing Hardware And Implementations |
US8714014B2 (en) | 2008-01-16 | 2014-05-06 | Life Technologies Corporation | System and method for acoustic focusing hardware and implementations |
US10976234B2 (en) | 2008-01-16 | 2021-04-13 | Life Technologies Corporation | System and method for acoustic focusing hardware and implementations |
WO2009118551A1 (fr) * | 2008-03-25 | 2009-10-01 | Prokyma Technologies Limited | Procédé d'analyse de sang par ultrasons pour la caractérisation du sang, la détection d'anticorps et la cytométrie en écoulement |
US8685168B2 (en) | 2008-06-06 | 2014-04-01 | Industrial Technology Research Institute | Method for removing micro-debris and device of the same |
US8614606B2 (en) | 2009-01-16 | 2013-12-24 | Salunda Limited | Delay-line self-oscillator |
WO2010082037A3 (fr) * | 2009-01-16 | 2010-10-21 | Isis Innovation Limited | Oscillateur acoustique |
US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
US10947493B2 (en) | 2012-03-15 | 2021-03-16 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10322949B2 (en) | 2012-03-15 | 2019-06-18 | Flodesign Sonics, Inc. | Transducer and reflector configurations for an acoustophoretic device |
US10662402B2 (en) | 2012-03-15 | 2020-05-26 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10689609B2 (en) | 2012-03-15 | 2020-06-23 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10724029B2 (en) | 2012-03-15 | 2020-07-28 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
US11007457B2 (en) | 2012-03-15 | 2021-05-18 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
US10737953B2 (en) | 2012-04-20 | 2020-08-11 | Flodesign Sonics, Inc. | Acoustophoretic method for use in bioreactors |
US10308928B2 (en) | 2013-09-13 | 2019-06-04 | Flodesign Sonics, Inc. | System for generating high concentration factors for low cell density suspensions |
US10975368B2 (en) | 2014-01-08 | 2021-04-13 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
US10052431B2 (en) | 2014-06-09 | 2018-08-21 | Ascent Bio-Nano Technologies, Inc. | System for manipulation and sorting of particles |
US10814253B2 (en) | 2014-07-02 | 2020-10-27 | Flodesign Sonics, Inc. | Large scale acoustic separation device |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US10773194B2 (en) | 2015-10-14 | 2020-09-15 | Sonosep Technologies Inc. | Methods, systems, and apparatuses for acoustically separating and washing particles |
WO2017063080A1 (fr) * | 2015-10-14 | 2017-04-20 | Sonosep Technologies Inc. | Procédés, systèmes et appareils permettant de séparer et de laver acoustiquement des particules |
EP3386652A4 (fr) * | 2015-10-14 | 2019-10-09 | Sonosep Technologies Inc. | Procédés, systèmes et appareils permettant de séparer et de laver acoustiquement des particules |
US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
CN106178008A (zh) * | 2016-07-06 | 2016-12-07 | 中山大学 | 一种超声‑压电协同杀菌技术 |
CN109844089A (zh) * | 2016-08-16 | 2019-06-04 | 弗洛设计声能学公司 | 使用声驻波的生物反应器 |
WO2018034655A1 (fr) * | 2016-08-16 | 2018-02-22 | Flodesign Sonics, Inc. | Bioréacteur utilisant des ondes stationnaires acoustiques |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
US11420136B2 (en) | 2016-10-19 | 2022-08-23 | Flodesign Sonics, Inc. | Affinity cell extraction by acoustics |
US10785574B2 (en) | 2017-12-14 | 2020-09-22 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
CN114286716A (zh) * | 2019-05-16 | 2022-04-05 | 费利克斯·特兰普勒 | 用于产生驻波超声场的装置 |
WO2020227747A1 (fr) * | 2019-05-16 | 2020-11-19 | Felix Trampler | Dispositif de production d'un champ ultrasonore stationnaire |
Also Published As
Publication number | Publication date |
---|---|
SE0100820D0 (sv) | 2001-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002072236A1 (fr) | Separation de particules | |
JP5827971B2 (ja) | 生物学的サンプルろ過中の超音波、逆流洗浄、およびフィルタ運動によるフィルタ洗浄装置および方法 | |
CN109069714B (zh) | 多血袋系统 | |
US11324873B2 (en) | Acoustic blood separation processes and devices | |
KR101672063B1 (ko) | 유체 샘플로부터 고체 부분을 분리하는 분리 장치 및 분리 방법 | |
AU699784B2 (en) | Apparatus and method for particle concentration and separation in a closed field | |
Hultström et al. | Proliferation and viability of adherent cells manipulated by standing-wave ultrasound in a microfluidic chip | |
US20110111497A1 (en) | Cell separation apparatus, method for activating fat-derived cells, graft material producing process, and graft material | |
US7118852B2 (en) | Methods and apparatus for decontaminating fluids | |
US20040069708A1 (en) | System and method for treating whole blood | |
KR101712569B1 (ko) | 혈액 처리 | |
WO2017041102A1 (fr) | Procédés et dispositifs de séparation acoustique du sang | |
TW201818983A (zh) | 用於分離或富集化細胞的方法及組合物 | |
JP6756474B2 (ja) | 単核細胞の採集のための方法とシステム | |
JP2015500031A (ja) | 脂肪組織から非脂肪細胞を分離するための方法および装置 | |
KR20190016937A (ko) | 충격파 또는 기계적 충격을 사용한 세포의 분리, 해리 및/또는 탈응집 | |
AU2002306757B2 (en) | Methods and apparatus for decontaminating fluids | |
US20170218330A1 (en) | Systems and methods for the separation of cells from microcarriers using a spinning membrane | |
JP2022552704A (ja) | 音響泳動により誘導される移動を通じて粒子を処理、洗浄、トランスフェクションするための装置 | |
JP7429052B2 (ja) | 流体中の粒子の濃度を変えるためのシステムおよび方法 | |
US9821110B2 (en) | Systems and methods for minimizing loss of cellular components during apheresis | |
WO2022085341A1 (fr) | Système de préparation d'échantillons et procédé de préparation d'échantillons | |
JP2003334067A (ja) | 細胞の稀釈洗浄方法及び稀釈洗浄装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |